Opportunity Information: Apply for CDC RFA PS10 1098
Apply for CDC RFA PS10 1098
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strategic Information and Laboratory Quality Assurance Services to Improve the Monitoring and Delivery of HIV/AIDS Services in the Democratic Republic of Congo under the President s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Jan 19, 2010 and posted on Jan 19, 2010.
- Applicants must submit their applications by Mar 17, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The Programme National de Lutte contre les IST/SIDA (PNLS) was established in 1998 by the Ministry of Health to coordinate all HIV/AIDS related activities and services undertaken by the ministry, with an emphasis on surveillance, prevention, and care and treatment of people living with HIV/AIDS. PNLS is the only entity in DRC with a government mandate for this national level coordination and is therefore the only appropriate body to perform the work. The scope of PNLS work includes the collection and use of strategic information, capacity building among health professionals involved in HIV/AIDS services, strengthening of laboratory capacity at local, provincial, and national levels, and formulating and revising policy documents.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA PS10-1098) is a discretionary cooperative agreement from the U.S. Centers for Disease Control and Prevention (CDC) under PEPFAR, focused on strengthening how HIV/AIDS services are monitored and delivered in the Democratic Republic of Congo (DRC). The core purpose is to support the Programme National de Lutte contre les IST/SIDA (PNLS), the Ministry of Health entity created in 1998 with the national mandate to coordinate HIV/AIDS activities across the country. The grant centers on two closely linked areas: strategic information (the systems and practices used to collect, manage, analyze, and use HIV program data) and laboratory quality assurance (the processes that ensure HIV-related testing is accurate, reliable, and consistent across sites). By improving these functions, the award aims to make HIV prevention, care, and treatment services more measurable, more accountable, and ultimately more effective.
The program is designed to reinforce PNLS leadership in national HIV coordination, especially in surveillance and program monitoring. On the strategic information side, the work typically includes strengthening routine data collection and reporting, improving data quality, and expanding the use of data for decision-making at national, provincial, and facility levels. This can involve standardizing indicators, improving tools and procedures for recording and reporting, training and mentoring health workers who manage HIV data, and strengthening systems that turn raw numbers into actionable insights (for example, identifying gaps in testing coverage, monitoring treatment uptake and retention, or tracking outcomes across provinces). In practical terms, the goal is to ensure that HIV program managers and clinical teams have dependable information they can use to plan services, target resources, and measure whether interventions are working.
On the laboratory quality assurance side, the opportunity supports efforts to strengthen laboratory capacity across the health system, from local clinics to provincial and national reference laboratories. Quality assurance in an HIV context generally means establishing and maintaining standards so that HIV tests and related lab services produce accurate results and are performed consistently. Activities often include implementing quality management systems, supporting proficiency testing and external quality assessment, improving standard operating procedures, training laboratory staff, and strengthening supervision and troubleshooting mechanisms. Reliable laboratory performance is foundational for HIV programs because accurate testing affects every step that follows, from diagnosis and linkage to care to monitoring patients on treatment. The grant’s emphasis on laboratory quality assurance reflects the recognition that data quality and clinical quality depend heavily on the reliability of lab services.
Only one award was expected, reflecting the highly targeted nature of the funding and the specific national coordination role of PNLS. The eligibility language indicates that PNLS is effectively the sole intended recipient because it is the only entity in DRC with the government mandate to coordinate HIV/AIDS services at the national level. The announcement also highlights PNLS responsibilities beyond coordination, including strategic information collection and use, capacity building for health professionals involved in HIV services, strengthening laboratory systems at multiple levels, and developing or revising policy documents. This framing suggests the cooperative agreement was meant not merely to fund isolated activities, but to reinforce a national system for HIV program oversight and continuous improvement.
Financially, the opportunity listed an estimated total funding amount of $1,500,000, with an award ceiling of $300,000 and an award floor of $100,000. There was no cost sharing or matching requirement. The funding instrument was a cooperative agreement, which usually indicates substantial involvement by the CDC during implementation, such as technical collaboration, joint planning, and ongoing program oversight rather than a hands-off grant relationship. The opportunity fell under CFDA 93.067 (Global AIDS), consistent with PEPFAR-supported HIV programming.
Key dates show the announcement was posted and created on January 19, 2010, with an original and current closing date of March 17, 2010, and an archive date of April 16, 2010. For access issues related to the full announcement, the contact listed was the PGO TIMS Grants office at 770-488-2700 with a general email referenced in the notice. Overall, the grant was structured as a focused investment in the national backbone functions that enable a large HIV response to perform well: trustworthy information for management and policy decisions, and high-quality laboratory services that support accurate diagnosis and effective treatment monitoring.
Frequently Asked Questions (FAQs)
What is CDC RFA PS10-1098?
CDC RFA PS10-1098 is a discretionary cooperative agreement funding opportunity from the U.S. Centers for Disease Control and Prevention (CDC), under PEPFAR, focused on strengthening how HIV/AIDS services are monitored and delivered in the Democratic Republic of Congo (DRC).
What is the main purpose of this funding opportunity?
The core purpose is to support the Programme National de Lutte contre les IST/SIDA (PNLS) in strengthening two national "backbone" functions for the HIV response: strategic information (how HIV program data are collected, managed, analyzed, and used) and laboratory quality assurance (how HIV-related testing accuracy and consistency are maintained across sites).
Who is PNLS and why is it central to this award?
PNLS is a Ministry of Health entity created in 1998 with the national mandate to coordinate HIV/AIDS activities across the DRC. The opportunity is designed to reinforce PNLS leadership in national HIV coordination, especially in surveillance and program monitoring, and to support PNLS responsibilities in strengthening strategic information and laboratory systems.
What are the two main focus areas funded under this opportunity?
The grant centers on two closely linked areas:
- Strategic information: strengthening systems and practices used to collect, manage, analyze, and use HIV program data.
- Laboratory quality assurance: strengthening processes that ensure HIV-related testing is accurate, reliable, and consistent across laboratories and testing sites.
What does "strategic information" mean in this program?
In this context, strategic information refers to the full set of systems and practices used to generate actionable HIV program data. This includes routine data collection and reporting, data quality improvement, indicator standardization, training and mentoring for staff managing HIV data, and strengthening the use of data for decision-making at national, provincial, and facility levels.
What kinds of activities are typically included under the strategic information component?
Based on the description, strategic information work typically includes strengthening routine reporting, improving data quality, standardizing indicators, improving recording and reporting tools and procedures, training and mentoring health workers who manage HIV data, and strengthening the use of data to guide program decisions across levels of the health system.
How is the data intended to be used once strategic information systems are strengthened?
The goal is for HIV program managers and clinical teams to have dependable information they can use to plan services, target resources, and measure whether interventions are working. Examples given include identifying gaps in testing coverage, monitoring treatment uptake and retention, and tracking outcomes across provinces.
What does "laboratory quality assurance" mean in this opportunity?
Laboratory quality assurance refers to establishing and maintaining standards so HIV tests and related laboratory services produce accurate results and are performed consistently across sites. It is described as a foundational element because accurate testing affects diagnosis, linkage to care, and monitoring patients on treatment.
What kinds of activities are typically included under the laboratory quality assurance component?
Activities often include implementing quality management systems, supporting proficiency testing and external quality assessment, improving standard operating procedures, training laboratory staff, and strengthening supervision and troubleshooting mechanisms. The opportunity also emphasizes strengthening laboratory capacity across levels, from local clinics to provincial and national reference laboratories.
Why does the opportunity emphasize laboratory quality assurance?
The description links reliable laboratory performance to both clinical quality and data quality. If testing is not accurate and consistent, it undermines diagnosis and treatment monitoring, and it can also weaken the reliability of program data used for planning and accountability.
How does this opportunity aim to improve HIV services in the DRC?
By improving the systems that measure performance (strategic information) and ensuring the accuracy and reliability of HIV-related testing (laboratory quality assurance), the award aims to make HIV prevention, care, and treatment services more measurable, more accountable, and ultimately more effective.
Is this grant intended to fund isolated projects or broader national systems?
The framing suggests it is meant to reinforce a national system for HIV program oversight and continuous improvement, rather than fund disconnected activities. It focuses on national coordination functions, surveillance and monitoring leadership, and multi-level laboratory system strengthening.
How many awards were expected under this funding opportunity?
Only one award was expected, reflecting the targeted nature of the funding and the national coordination role of PNLS.
Who was eligible to apply?
The eligibility language indicates PNLS was effectively the sole intended recipient because it is the only entity in the DRC with the government mandate to coordinate HIV/AIDS services at the national level.
What additional responsibilities of PNLS are highlighted in the announcement?
Beyond coordination, the announcement highlights PNLS responsibilities that include strategic information collection and use, capacity building for health professionals involved in HIV services, strengthening laboratory systems at multiple levels, and developing or revising policy documents.
What is the total estimated funding amount for this opportunity?
The opportunity listed an estimated total funding amount of $1,500,000.
What were the award floor and award ceiling?
The award ceiling was $300,000 and the award floor was $100,000.
Was cost sharing or matching required?
No. The opportunity stated there was no cost sharing or matching requirement.
What is the funding instrument type and what does it imply?
The funding instrument was a cooperative agreement. This typically implies substantial involvement by CDC during implementation, such as technical collaboration, joint planning, and ongoing program oversight, rather than a fully hands-off grant relationship.
What CFDA program is associated with this funding?
The opportunity fell under CFDA 93.067 (Global AIDS), consistent with PEPFAR-supported HIV programming.
When was the announcement posted and when did it close?
Key dates provided include a posted/created date of January 19, 2010, and an original and current closing date of March 17, 2010. The archive date was April 16, 2010.
Who was listed as the contact for access issues related to the full announcement?
For access issues, the notice listed the PGO TIMS Grants office at 770-488-2700 and referenced a general email address in the notice.
What overall result is this cooperative agreement trying to achieve?
Overall, the award is described as a focused investment in the national backbone functions that enable a large HIV response to perform well: trustworthy information for management and policy decisions, and high-quality laboratory services that support accurate diagnosis and effective treatment monitoring.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: USAID/DCHA/CMM Annual Program Statement (APS) for Conflict Mitigation and Reconciliation Programs and Activities
Previous opportunity: Expanded Support for Healthcare Systems Strengthening Activities within the Ministry of Health and Social Services in the Republic of Namibia under the President s Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS10 1098
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS10 1098) also looked into and applied for these:
| Funding Opportunity |
|---|
| Inform Decision Makers to Act (IDEA) APS Apply for MOAAGHPOP 19 0110 Funding Number: MOAAGHPOP 19 0110 Agency: Agency for International Development Category: Health Funding Amount: $15,000,000 |
| Faculty Development Integrated Technology into Nursing Education and Practice Initiative Apply for HRSA 10 061 Funding Number: HRSA 10 061 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Small Health Care Provider Quality Improvement Apply for HRSA 10 045 Funding Number: HRSA 10 045 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Prevention and Management of Healthcare Associated Infections (R18) Apply for PA 10 089 Funding Number: PA 10 089 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| ARRA OS Recovery Act 2009 Limited Competition Scalable Distributed Research Networks for Comparative Effectiveness Research (R01) Apply for RFA HS 10 015 Funding Number: RFA HS 10 015 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $2,770,000 |
| Improving Patient Safety through Simulation Research (R18) Apply for RFA HS 10 018 Funding Number: RFA HS 10 018 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $350,000 |
| NINDS Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows in MD PhD programs (F31) Apply for PAR 10 091 Funding Number: PAR 10 091 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| SSA Work Incentives Planning and Assistance Projects Apply for SSA OAG 10 1 Funding Number: SSA OAG 10 1 Agency: ODISP OESP Category: Health Funding Amount: $300,000 |
| Medicare Rural Hospital Flexibility Apply for HRSA 10 049 Funding Number: HRSA 10 049 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Part C CAPACITY DEVELOPMENT Apply for HRSA 10 018 Funding Number: HRSA 10 018 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Rapid Strengthening and Expansion of Integrated Social Services for People Infected and Affected by HIV/AIDS in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1077 Funding Number: CDC RFA PS10 1077 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Expansion of HIV/AIDS Prevention and Care Interventions Among Rural Populations in the Republic of Cte d Ivoire Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1030 Funding Number: CDC RFA PS10 1030 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Strengthening Community Based HIV/AIDS Prevention and Care Services in the Underserved Northern and Western Regions of the Republic of Cte d Ivoire Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1033 Funding Number: CDC RFA PS10 1033 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Integrated HIV Prevention Program for the Federal Police Force of Ethiopia under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10110 Funding Number: CDC RFA PS10 10110 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Developing Advanced HIV/AIDS Program Apply for CDC RFA PS10 1017 Funding Number: CDC RFA PS10 1017 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,000,000 |
| Partnering with the Hanoi School of Public Health in Vietnam to Enhance Health Workforce Development, Health Systems Strengthening and Public Health Informatics Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10154 Funding Number: CDC RFA PS10 10154 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Research Grants for Preventing Violence and Violence Related Injury (R01) Apply for RFA CE10 005 Funding Number: RFA CE10 005 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Purchase, Distribution and Tracking of Cotrimoxazole, HIV/AIDS Related Laboratory Commodities and Supplies in the Republic of Uganda Under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1025 Funding Number: CDC RFA PS10 1025 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $9,007,459 |
| Investigator Initiated Multi Site Clinical Trials (Collaborative R01) Apply for PAR 10 096 Funding Number: PAR 10 096 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Support for a National Monitoring and Evaluation System, Strategic Information Coordination, Data Synthesis, and Data Use to Strengthen the Multi Sector HIV/AIDS Response in the United Republic of Tanzania Under PEPFAR Apply for CDC RFA PS10 1069 Funding Number: CDC RFA PS10 1069 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 1098", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.